Loading...
Not a good buy right now for an impatient buyer. TWI is in a short-term uptrend but is trading near resistance (post-market 9.54 vs R2 ~9.72) with RSI elevated (70.7) and pattern-based odds pointing to mild downside over the next day/week/month. With no proprietary buy signals today and weak latest-quarter profitability, the risk/reward for buying immediately is unfavorable; better entries would be closer to the pivot (9.06) or support (8.66).
Trend is bullish but stretched. Moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200) and MACD histogram is positive and expanding (0.0291), confirming upside momentum. However, RSI_6 at ~70.7 suggests the stock is extended and vulnerable to a pullback. Price is currently above R1 (9.465) and approaching R2 (9.715); immediate support levels are Pivot 9.06, then S1 8.655. Similar-pattern stats indicate a 60% chance of small declines: ~-0.57% next day, -1.49% next week, -2.87% next month.

Technical uptrend confirmed by bullish MA stack and improving MACD momentum. Hedge funds are net buyers with buying amount up 150.78% QoQ, which can support price. Gross margin improved to ~14.45% in 2025/Q3 (+14.5% YoY), a constructive operating signal.
while price is near resistance (R2 ~9.715), increasing pullback risk. Latest quarter (2025/Q
profitability deteriorated sharply: net income -$2.262M (-87.6% YoY) and EPS -0.04 (-84% YoY). No news catalysts in the last week to justify a momentum breakout. Pattern-based forward stats lean modestly negative over the next day/week/month.
Latest reported quarter is 2025/Q3: revenue rose to $466.5M (+4.13% YoY), showing modest top-line growth. Gross margin improved to ~14.45% (+14.5% YoY), but earnings weakened significantly with net income turning/remaining negative (-$2.262M) and EPS at -0.04, indicating margin gains have not translated into bottom-line strength yet.
No analyst rating or price target change data was provided, so there is no confirmed recent trend in Wall Street ratings/targets. Based on the available fundamentals, likely 'pro' view: revenue growth and improving gross margin with institutional buying interest; likely 'con' view: negative/declining earnings and limited near-term catalysts, making rallies prone to fade.